HEADER DNA BINDING PROTEIN/AGONIST 27-APR-18 6D94 TITLE CRYSTAL STRUCTURE OF PPAR GAMMA IN COMPLEX WITH MEDIATOR OF RNA TITLE 2 POLYMERASE II TRANSCRIPTION SUBUNIT 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION SUBUNIT 1; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: ACTIVATOR-RECRUITED COFACTOR 205 KDA COMPONENT,ARC205, COMPND 10 MEDIATOR COMPLEX SUBUNIT 1,PEROXISOME PROLIFERATOR-ACTIVATED COMPND 11 RECEPTOR-BINDING PROTEIN,PPAR-BINDING PROTEIN,THYROID HORMONE COMPND 12 RECEPTOR-ASSOCIATED PROTEIN COMPLEX 220 KDA COMPONENT,TRAP220,THYROID COMPND 13 RECEPTOR-INTERACTING PROTEIN 2,TRIP-2,VITAMIN D RECEPTOR-INTERACTING COMPND 14 PROTEIN COMPLEX COMPONENT DRIP205,P53 REGULATORY PROTEIN RB18A; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) GOLD; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET45B; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, SUPER AGONIST, LIGAND BINDING KEYWDS 2 DOMAIN, COACTIVATOR, MED1, DNA BINDING PROTEIN, DNA BINDING PROTEIN- KEYWDS 3 AGONIST COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.C.MOU,I.M.CHRISMAN,T.S.HUGHES,S.R.SPRANG REVDAT 4 25-OCT-23 6D94 1 REMARK REVDAT 3 01-MAR-23 6D94 1 JRNL REVDAT 2 25-DEC-19 6D94 1 REMARK REVDAT 1 01-MAY-19 6D94 0 JRNL AUTH M.D.NEMETCHEK,I.M.CHRISMAN,M.L.RAYL,A.H.VOSS,T.S.HUGHES JRNL TITL A STRUCTURAL MECHANISM OF NUCLEAR RECEPTOR BIASED AGONISM. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 33119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 36469765 JRNL DOI 10.1073/PNAS.2215333119 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13RC2_2975: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.420 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 23568 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.160 REMARK 3 FREE R VALUE TEST SET COUNT : 1688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.8231 - 4.3487 0.99 1930 152 0.1546 0.1880 REMARK 3 2 4.3487 - 3.4522 1.00 1865 139 0.1411 0.2148 REMARK 3 3 3.4522 - 3.0159 1.00 1846 136 0.1846 0.2541 REMARK 3 4 3.0159 - 2.7402 1.00 1813 149 0.2119 0.2814 REMARK 3 5 2.7402 - 2.5438 1.00 1845 141 0.2137 0.2996 REMARK 3 6 2.5438 - 2.3939 0.99 1807 143 0.2180 0.2886 REMARK 3 7 2.3939 - 2.2740 0.99 1806 149 0.2211 0.2805 REMARK 3 8 2.2740 - 2.1750 0.99 1798 132 0.2437 0.2919 REMARK 3 9 2.1750 - 2.0913 0.99 1776 157 0.2562 0.3064 REMARK 3 10 2.0913 - 2.0191 0.99 1802 144 0.2824 0.3775 REMARK 3 11 2.0191 - 1.9560 0.99 1805 117 0.3234 0.3424 REMARK 3 12 1.9560 - 1.9001 0.99 1787 129 0.3684 0.4026 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 2374 REMARK 3 ANGLE : 1.259 3196 REMARK 3 CHIRALITY : 0.064 365 REMARK 3 PLANARITY : 0.008 405 REMARK 3 DIHEDRAL : 6.835 1452 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -22.1812 -12.4254 13.6930 REMARK 3 T TENSOR REMARK 3 T11: 0.1391 T22: 0.3881 REMARK 3 T33: 0.1959 T12: 0.0719 REMARK 3 T13: -0.0678 T23: -0.0629 REMARK 3 L TENSOR REMARK 3 L11: 2.3830 L22: 2.8080 REMARK 3 L33: 4.1167 L12: -0.4007 REMARK 3 L13: -0.9250 L23: 1.4757 REMARK 3 S TENSOR REMARK 3 S11: -0.2297 S12: -0.1992 S13: -0.0517 REMARK 3 S21: 0.2378 S22: 0.4392 S23: -0.2741 REMARK 3 S31: -0.0691 S32: 0.6927 S33: -0.0527 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6D94 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-18. REMARK 100 THE DEPOSITION ID IS D_1000234199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23571 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 43.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 9.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TTO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES 25% (W/V) PEG 2000 MME, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.78050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.78050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 27.71850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.81150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 27.71850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.81150 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 60.78050 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 27.71850 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.81150 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 60.78050 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 27.71850 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 43.81150 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 707 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 719 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 181 REMARK 465 ALA A 182 REMARK 465 HIS A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 VAL A 189 REMARK 465 ASP A 190 REMARK 465 ASP A 191 REMARK 465 ASP A 192 REMARK 465 ASP A 193 REMARK 465 LYS A 194 REMARK 465 MET A 195 REMARK 465 GLU A 196 REMARK 465 ASN A 197 REMARK 465 LEU A 198 REMARK 465 TYR A 199 REMARK 465 PHE A 200 REMARK 465 GLN A 201 REMARK 465 GLY A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 VAL B 278 REMARK 465 SER B 279 REMARK 465 SER B 280 REMARK 465 MET B 281 REMARK 465 ALA B 282 REMARK 465 ASN B 298 REMARK 465 PRO B 299 REMARK 465 ALA B 300 REMARK 465 GLN B 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 428 79.88 -111.10 REMARK 500 ASP A 462 78.73 48.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDK A 501 DBREF 6D94 A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 6D94 B 278 301 UNP Q15648 MED1_HUMAN 632 655 SEQADV 6D94 MET A 181 UNP P37231 INITIATING METHIONINE SEQADV 6D94 ALA A 182 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 183 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 184 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 185 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 186 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 187 UNP P37231 EXPRESSION TAG SEQADV 6D94 HIS A 188 UNP P37231 EXPRESSION TAG SEQADV 6D94 VAL A 189 UNP P37231 EXPRESSION TAG SEQADV 6D94 ASP A 190 UNP P37231 EXPRESSION TAG SEQADV 6D94 ASP A 191 UNP P37231 EXPRESSION TAG SEQADV 6D94 ASP A 192 UNP P37231 EXPRESSION TAG SEQADV 6D94 ASP A 193 UNP P37231 EXPRESSION TAG SEQADV 6D94 LYS A 194 UNP P37231 EXPRESSION TAG SEQADV 6D94 MET A 195 UNP P37231 EXPRESSION TAG SEQADV 6D94 GLU A 196 UNP P37231 EXPRESSION TAG SEQADV 6D94 ASN A 197 UNP P37231 EXPRESSION TAG SEQADV 6D94 LEU A 198 UNP P37231 EXPRESSION TAG SEQADV 6D94 TYR A 199 UNP P37231 EXPRESSION TAG SEQADV 6D94 PHE A 200 UNP P37231 EXPRESSION TAG SEQADV 6D94 GLN A 201 UNP P37231 EXPRESSION TAG SEQADV 6D94 GLY A 202 UNP P37231 EXPRESSION TAG SEQRES 1 A 297 MET ALA HIS HIS HIS HIS HIS HIS VAL ASP ASP ASP ASP SEQRES 2 A 297 LYS MET GLU ASN LEU TYR PHE GLN GLY GLN LEU ASN PRO SEQRES 3 A 297 GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR SEQRES 4 A 297 ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS SEQRES 5 A 297 ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER SEQRES 6 A 297 PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY SEQRES 7 A 297 GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN SEQRES 8 A 297 GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY SEQRES 9 A 297 CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR SEQRES 10 A 297 GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP SEQRES 11 A 297 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS SEQRES 12 A 297 GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS SEQRES 13 A 297 ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR SEQRES 14 A 297 ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP SEQRES 15 A 297 PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN SEQRES 16 A 297 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE SEQRES 17 A 297 ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU SEQRES 18 A 297 ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU SEQRES 19 A 297 GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SEQRES 20 A 297 SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR SEQRES 21 A 297 ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU SEQRES 22 A 297 GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS SEQRES 23 A 297 PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 24 VAL SER SER MET ALA GLY ASN THR LYS ASN HIS PRO MET SEQRES 2 B 24 LEU MET ASN LEU LEU LYS ASP ASN PRO ALA GLN HET EDK A 501 37 HETNAM EDK (2~{S})-3-[4-[2-[METHYL(PYRIDIN-2-YL) HETNAM 2 EDK AMINO]ETHOXY]PHENYL]-2-[[2-(PHENYLCARBONYL) HETNAM 3 EDK PHENYL]AMINO]PROPANOIC ACID FORMUL 3 EDK C30 H29 N3 O4 FORMUL 4 HOH *131(H2 O) HELIX 1 AA1 GLU A 207 PHE A 226 1 20 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 GLU A 259 1 9 HELIX 4 AA4 ASP A 260 ILE A 262 5 3 HELIX 5 AA5 PRO A 269 GLN A 273 5 5 HELIX 6 AA6 GLU A 276 SER A 302 1 27 HELIX 7 AA7 GLY A 305 LEU A 309 5 5 HELIX 8 AA8 ASP A 310 SER A 332 1 23 HELIX 9 AA9 SER A 342 GLY A 344 5 3 HELIX 10 AB1 ARG A 350 SER A 355 1 6 HELIX 11 AB2 PRO A 359 PHE A 363 5 5 HELIX 12 AB3 MET A 364 ALA A 376 1 13 HELIX 13 AB4 ASP A 380 LEU A 393 1 14 HELIX 14 AB5 ASN A 402 HIS A 425 1 24 HELIX 15 AB6 GLN A 430 GLU A 460 1 31 HELIX 16 AB7 HIS A 466 LYS A 474 1 9 HELIX 17 AB8 ASN B 284 ASN B 287 5 4 HELIX 18 AB9 HIS B 288 LYS B 296 1 9 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N PHE A 247 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 CISPEP 1 LYS A 358 PRO A 359 0 2.33 SITE 1 AC1 15 PHE A 282 GLY A 284 CYS A 285 GLN A 286 SITE 2 AC1 15 SER A 289 HIS A 323 LEU A 330 ILE A 341 SITE 3 AC1 15 MET A 348 PHE A 360 PHE A 363 MET A 364 SITE 4 AC1 15 HIS A 449 TYR A 473 HOH A 643 CRYST1 55.437 87.623 121.561 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011413 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008226 0.00000